163 related articles for article (PubMed ID: 25683228)
1. Uveitic macular oedema after treatment with vemurafenib.
Fonollosa A; Mesquida M; Adan A
Acta Ophthalmol; 2015 Dec; 93(8):e686-7. PubMed ID: 25683228
[No Abstract] [Full Text] [Related]
2. Bilateral panuveitis in a patient on vemurafenib BRAF inhibitor therapy for stage IV melanoma.
Agemy SA; Mehta AN; Pachydaki SI; Tewari A
Eur J Ophthalmol; 2014; 24(4):629-32. PubMed ID: 24474376
[TBL] [Abstract][Full Text] [Related]
3. Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema.
Munk MR; Ram R; Rademaker A; Liu D; Setlur V; Chau F; Schmidt-Erfurth U; Goldstein DA
Acta Ophthalmol; 2015 Nov; 93(7):e561-7. PubMed ID: 25708777
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
5. RASopathic alopecia: hair changes associated with vemurafenib therapy.
Piraccini BM; Patrizi A; Fanti PA; Starace M; Bruni F; Melotti B; Misciali C; Dika E
J Am Acad Dermatol; 2015 Apr; 72(4):738-41. PubMed ID: 25773419
[No Abstract] [Full Text] [Related]
6. Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib.
Gebhardt C; Staub J; Schmieder A; Goerdt S; Utikal J
Acta Derm Venereol; 2015 Jan; 95(1):96-7. PubMed ID: 24710689
[No Abstract] [Full Text] [Related]
7. Uveitis in patients with late-stage cutaneous melanoma treated with vemurafenib.
Guedj M; Quéant A; Funck-Brentano E; Kramkimel N; Lellouch J; Monnet D; Longvert C; Gantzer A; Brézin AP
JAMA Ophthalmol; 2014 Dec; 132(12):1421-5. PubMed ID: 25125216
[TBL] [Abstract][Full Text] [Related]
8. Abrupt development of Dupuytren's contractures with the BRAF inhibitor vemurafenib.
Sibaud V; Chevreau C
Joint Bone Spine; 2014 Jul; 81(4):373-4. PubMed ID: 24468667
[No Abstract] [Full Text] [Related]
9. Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib.
Choe CH; McArthur GA; Caro I; Kempen JH; Amaravadi RK
Am J Ophthalmol; 2014 Oct; 158(4):831-837.e2. PubMed ID: 25036880
[TBL] [Abstract][Full Text] [Related]
10. Vemurafenib-induced DRESS.
Wenk KS; Pichard DC; Nasabzadeh T; Jang S; Venna SS
JAMA Dermatol; 2013 Oct; 149(10):1242-3. PubMed ID: 23986488
[No Abstract] [Full Text] [Related]
11. Iluvien Implantation for Uveitis and Uveitic Macular Edema.
Reddy AK; Burkholder BM; Khan IR; Thorne JE
Ocul Immunol Inflamm; 2018; 26(2):315-316. PubMed ID: 27736275
[No Abstract] [Full Text] [Related]
12. Tomographic assessment of therapeutic response to uveitic macular oedema.
Sivaprasad S; Ikeji F; Xing W; Lightman S
Clin Exp Ophthalmol; 2007 Nov; 35(8):719-23. PubMed ID: 17997774
[TBL] [Abstract][Full Text] [Related]
13. Histopathological features of cutaneous drug reactions to vemurafenib: a report of two cases.
Dabner M; Harvey NT; Soma A; Wood BA
Pathology; 2012 Dec; 44(7):661-4. PubMed ID: 23172086
[No Abstract] [Full Text] [Related]
14. Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.
van den Brom RR; Mäkelburg AB; Schröder CP; de Vries EG; Hospers GA
J Clin Oncol; 2015 Dec; 33(36):e133-4. PubMed ID: 24778390
[No Abstract] [Full Text] [Related]
15. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
Morrison VL; Kozak I; LaBree LD; Azen SP; Kayicioglu OO; Freeman WR
Ophthalmology; 2007 Feb; 114(2):334-9. PubMed ID: 17270681
[TBL] [Abstract][Full Text] [Related]
16. Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma.
Wolf SE; Meenken C; Moll AC; Haanen JB; van der Heijden MS
BMC Cancer; 2013 Dec; 13():561. PubMed ID: 24289205
[TBL] [Abstract][Full Text] [Related]
17. Vemurafenib and cutaneous adverse events--report of five cases.
Silva Gde B; Mendes AP; de Macedo MP; Pinto CA; Gibbons IL; Duprat Neto JP
An Bras Dermatol; 2015; 90(3 Suppl 1):242-6. PubMed ID: 26312729
[TBL] [Abstract][Full Text] [Related]
18. Vemurafenib-induced bilateral facial palsy.
Shailesh FN; Singh M; Tiwari U; Hutchins LF
J Postgrad Med; 2014; 60(2):187-8. PubMed ID: 24823520
[TBL] [Abstract][Full Text] [Related]
19. Toxic epidermal necrolysis induced by vemurafenib.
Lapresta A; Dotor A; González-Herrada C
Actas Dermosifiliogr; 2015 Oct; 106(8):682-3. PubMed ID: 26051238
[No Abstract] [Full Text] [Related]
20. Structural and functional outcomes after treatment of uveitic macular oedema: an optical coherence tomography and multifocal electroretinogram study.
Georgiadou E; Moschos MM; Margetis I; Chalkiadakis J; Markomichelakis NN
Clin Exp Optom; 2012 Jan; 95(1):89-93. PubMed ID: 22098256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]